Top 10 Life Science Angel Investors in France (August 2026)
For AI agents: Short investor table (Markdown), Detailed investor list (Markdown)
| Investor | Relevant Deals | Geography | Stage | Focus | Round Size |
|---|---|---|---|---|---|
|
Bertrand Jacquelot
Angel
|
2 | France, United States | Pre-Seed, Seed, Angel | Food and Beverage, E-Commerce, Information Technology | $120k–$7.8M |
|
Bernard Majoie
Angel
|
2 | France, Belgium | Seed, Pre-Seed, Series A | Biotechnology, Medical, Health Care | $1.3M–$2.7M |
|
Andrew Nutter
Angel
|
2 | France, United Kingdom, United States | Seed, Pre-Seed, Series A | Software, SaaS, FinTech | $550k–$4.9M |
|
Sylvain Zimmer
Angel
|
2 | France, United States, United Kingdom | Seed, Pre-Seed, Angel | Software, SaaS, Food and Beverage | $200k–$10M |
|
Fidji Simo
Angel
|
1 | United States, United Kingdom, Canada | Seed, Series A, Series B | Software, Health Care, Internet | $1.2M–$250M |
|
Christophe Ricard
Angel
|
1 | France | Seed, Series B | Life Science, Biotechnology, Medical Device | |
|
Irwan Bello
Angel
|
1 | France, United States | Seed, Pre-Seed | Internet, Information Technology, Artificial Intelligence | $2.5M–$11M |
|
Jacques Lewiner
Angel
|
1 | France | Seed, Series C | Biotechnology, Medical, Health Care | |
|
Xavier Niel
Angel
|
1 | France, United States, United Kingdom | Seed, Series A | Software, Artificial Intelligence, SaaS | $1M–$70M |
|
Sebastian Lombardo
Angel
|
1 | France, United States | Seed | Apps, Internet, Lifestyle | $2.5M–$3.1M |
| Access all 13 angel investors in France Life Science startups. | |||||
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Investor list
Bertrand Jacquelot is the Founding President of Projim. He attended the University of Marne-la-Vallee.
Show more...Investment focus
- Industry: Food and Beverage, E-Commerce, Information Technology
- Stage:Pre-Seed, Seed, Angel
- Geography: France, United States
Investor stats
- Total investments: 20
- Round size: Seed $1.5M–$7.8M; Pre-Seed $120k–$1.1M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Bolk — Bolk provides autonomous bowl-making robotic canteen which producing warm meals, cold dishes and desserts from precooked ingredients.
- Arkania — B2B API solution for brands to create and sell online NFTs directly on their platforms
- Starton — Integrate blockchain technology this week. Focus on your vision, we handle blockchain complexity
Bernard Majoie - President @ Fournier-Majoie
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Pre-Seed, Series A
- Geography: France, Belgium
Investor stats
- Total investments: 6
- Round size: Seed $1.3M–$2.7M
- Lead/follow: 33% lead, 67% follow
Portfolio highlights
- reMYND — Driving the development of disease-modifying treatments
- AgenT — AgenT develops the first blood diagnosis to detect Alzheimer's years before the onset of the irreversible symptoms.
- PEP-Therapy — PEP-Therapy is a French biotechnology company developing first-in-class peptides as targeted therapies in oncology
Andrew Nutter is a Co-Founder at Gama. He attended Stanford University.
Show more...Investment focus
- Industry: Software, SaaS, FinTech
- Stage:Seed, Pre-Seed, Series A
- Geography: France, United Kingdom, United States
Investor stats
- Total investments: 25
- Round size: Seed $550k–$4.9M; Pre-Seed $809k–$3.4M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Yavin — Yavin provides modern point-of-sale solutions for European merchants. Yavin is a tool to receive payments, sell smarter, and grow the business.
- Gama — Thanks to cheap, reliable and scalable solar sails, we are redefining deep space access.
- EV Biotech — We design and optimise your precision fermentation strains and processes, tailored to your success.
Sylvain Zimmer is based out of Paris, Ile-de-France and is the Chief Technology Officer of La Suite territoriale (EIG) of Direction interministérielle du numérique. Sylvain previously worked at Contentsquare as a head of the CTO office. Sylvain Zimmer attended the National School of Computer Science and Applied Mathematics of Grenoble.
Show more...Investment focus
- Industry: Software, SaaS, Food and Beverage
- Stage:Seed, Pre-Seed, Angel
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 26
- Round size: Seed $637k–$10M; Angel $400k–$500k; Pre-Seed $200k–$2M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- GOURMEY — We create sustainable cultivated meat delights for an uncompromising and conscious generation.
- Waldo — The codeless way to quickly build a comprehensive test suite for teams who don't compromise on speed and quality.
- TOTEM — A Totem is a place of sharing and conviviality in your office. This is an opportunity for your colleagues to get to know each other better, celebrate victories and defeats together, and build a solid culture.
Fidji Simo is the CEO and Chair of the Board of Directors of Instacart. She previously worked at Facebook as a Head of the Facebook App. Fidji Simo attended HEC Paris.
Show more...Investment focus
- Industry: Software, Health Care, Internet
- Stage:Seed, Series A, Series B
- Geography: United States, United Kingdom, Canada
Investor stats
- Total investments: 23
- Round size: Seed $1.2M–$12M; Series A $10M–$48M; Series B $28M–$250M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Breezy — Breezy is a mobile-first AI workspace for real estate agents that provides virtual assistant services and CRM systems for realtors and brokerages.
- BuildForever — BuildForever build products that feel personal, magical and deeply human.
- Beacon Software — Beacon acquires and grows essential businesses with permanent capital and a centralized operating platform.
Christophe Ricard CEO of OM Pharma
Show more...Investment focus
- Industry: Life Science, Biotechnology, Medical Device
- Stage:Seed, Series B
- Geography: France
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Antabio — Antabio develops novel antibiotics against drug-resistant Gram-negative bacteria and antimicrobial resistance.
Irwan Bello is an individual investor.
Show more...Investment focus
- Industry: Internet, Information Technology, Artificial Intelligence
- Stage:Seed, Pre-Seed
- Geography: France, United States
Investor stats
- Total investments: 5
- Round size: Seed $3.8M–$11M; Pre-Seed $2.5M–$3M
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
- Twin — Twin Labs, offer an automated tool for repetitive operations, such as onboarding new staff to all internal systems.
- Swish Robotics — Embodied Intelligence for the Home
Jacques Lewiner - Member of the Board of Directors @ Axilum Robotics
Show more...Investment focus
- Industry: Biotechnology, Medical, Health Care
- Stage:Seed, Series C
- Geography: France
Investor stats
- Total investments: 2
- Lead/follow: 0% lead, 100% follow
Portfolio highlights
- Cytoo — Pioneering muscle pathology research with our exclusive MyoScreen platform to accelerate drug target identification and therapeutic innovation.
- Okomera — Automated 3D model drug testing of cancer biopsies prior to treatment. For precision and personalized medicine. The "test before you treat" solution for every oncologist and patient.
Xavier Niel is based out of Paris, Ile-de-France and is the Co-Founder and CEO of NJJ Capital. Xavier previously worked at Worldnet as a Founder. Xavier Niel attended Saint Michel de Picpus Catholic private high school.
Show more...Investment focus
- Industry: Software, Artificial Intelligence, SaaS
- Stage:Seed, Series A
- Geography: France, United States, United Kingdom
Investor stats
- Total investments: 136
- Round size: Seed $1M–$70M; Series A $3M–$20M
- Lead/follow: 14% lead, 86% follow
Portfolio highlights
- Qutwo — We unite Qutwo OS and world-class AI and quantum scientists with the most forward-looking enterprises to develop competitive edge through classical AI, hybrid, and full quantum systems. We tackle the most challenging problems in AI computing.
- HrFlow.ai — Meet the first AI agents and Foundation models trained on billions of interview outcomes. The Hiring SuperIntelligence predicts your next hires and who's worth meeting, saving managers thousands of hours wasted on false positives.
- Advanced Machine Intelligence — AMI - Advanced Machine Intelligence - builds world-model-based AI that understands the real world. We develop safe, controllable intelligent systems for industry, robotics, healthcare, and beyond.
Sebastian Lombardo - CEO @ Valtech
Show more...Investment focus
- Industry: Apps, Internet, Lifestyle
- Stage:Seed
- Geography: France, United States
Investor stats
- Total investments: 2
- Round size: Seed $2.5M–$3.1M
- Lead/follow: 50% lead, 50% follow
Portfolio highlights
- Jop — A one-stop-shop for urban residents, Jop offers a variety of on-demand services in one convenient, easy-to-use platform. Customers can tap a screen and connect with a professional in their city, whether they are an expert at cleaning apartments, trimming mustaches, walking dogs, doing makeup, DJing, or mixing drinks. Instead of paying a company’soverhead, customers pay a Jopper. Once booked, Joppers arrive right at the customer’s doorstep, ready to work.Founded by Canel Frichet and Sebastian Lombardo, Jop was born as a platform to give people the opportunity to work directly for each other, as opposed to hiring through a company. Joppers set their own pricing and hours. Something else that sets JOP apart from other platforms in the on-demand space is that Joppers earn company equity, which is granted based on level of activity and performance on the platform.
- Smart Immune — Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change the prognosis and life quality of patients with devastating diseases. The company's first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34-; CD5- cells)curative power to enable a short, polyclonal, and safe post-transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new-generation treatments for a wide variety of inherited blood disorders and blood cancers.
Life Science Angel investor funding in France at a glance
Stats across 15 deals from 13 investors.
Access all 13 angel investors in France Life Science startups.
Open ListFAQ
Is Shizune data fresh/accurate?
Shizune has monitored hundreds of funding sources since 2020.
Our investor database is updated every day, so investor data is always fresh.
All metrics are calculated from confirmed public rounds, so the data is accurate.
Can I download investor list?
To download the Life Science Angel Investors in France investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.
You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.
Can I access investor database?
To access all 13 angel investors investing in France Life Science startups and 48,091+ more investors, create a Shizune account.
Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.
The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.
You can enrich with email and download the data.
Does Shizune have investor emails and contacts?
Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.
To guarantee the highest discovery rate, we search across 20+ contact search tools.
To maximize delivery rate and reduce bounce rate, we validate emails.
You can enrich your investor list with Shizune. Download it too.
What is Shizune?
Shizune is a 48,091 investor database updated daily.
With Shizune you can:
- browse the database
- use smart matching
- enrich with emails
- download
All you need to find investors for your startup.
Who is Shizune for?
Shizune is built for startup founders by startup founders.
If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.
Is Shizune free?
Shizune is free forever. You can search and browse investors for free.
Email search and export are paid features.
For full info, visit our pricing.
Who built Shizune?
Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.
Contact 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!